Current limitations and future opportunities for epigenetic therapies
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current limitations and future opportunities for epigenetic therapies
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 4, Issue 4, Pages 425-446
Publisher
Future Science, LTD
Online
2012-03-15
DOI
10.4155/fmc.12.7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Signals and Combinatorial Functions of Histone Modifications
- (2011) Tamaki Suganuma et al. Annual Review of Biochemistry
- Inhibitors of histone demethylases
- (2011) Brian Lohse et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- Cancer epigenetics: linking basic biology to clinical medicine
- (2011) Hsing-Chen Tsai et al. CELL RESEARCH
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- On the Determination of the Stereochemistry of Semisynthetic Natural Product Analogues using Chiroptical Spectroscopy: Desulfurization of Epidithiodioxopiperazine Fungal Metabolites
- (2011) Fanny Cherblanc et al. CHEMISTRY-A EUROPEAN JOURNAL
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
- (2011) Patrick Brest et al. ENDOCRINE-RELATED CANCER
- Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?
- (2011) Florian Thaler et al. Expert Opinion on Drug Discovery
- Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines
- (2011) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
- (2011) A. Nebbioso et al. MOLECULAR CANCER THERAPEUTICS
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
- (2011) Masoud Vedadi et al. Nature Chemical Biology
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9
- (2010) Shuichi Mori et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Epigenetic profiling of the antitumor natural product psammaplin A and its analogues
- (2010) José García et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases
- (2010) James Dowden et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- (2010) D. B. Yap et al. BLOOD
- Cancer Epigenetics
- (2010) Rodolphe Taby et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
- (2010) Warren Fiskus et al. CANCER BIOLOGY & THERAPY
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Structure and Function of Mammalian DNA Methyltransferases
- (2010) Renata Zofia Jurkowska et al. CHEMBIOCHEM
- Methylation, a new epigenetic mark for protein stability
- (2010) Xiao-Dong Yang et al. Epigenetics
- SET7/9 mediated methylation of non-histone proteins in mammalian cells
- (2010) Sriharsa Pradhan et al. Epigenetics
- G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53
- (2010) Jing Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
- (2010) Daisy PF Tsang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.
- (2010) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
- (2010) Yanqi Chang et al. JOURNAL OF MOLECULAR BIOLOGY
- Total Synthesis of (+)-Chaetocin and its Analogues: Their Histone Methyltransferase G9a Inhibitory Activity
- (2010) Eriko Iwasa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- An Acetylation Switch Modulates the Transcriptional Activity of Estrogen-Related Receptor α
- (2010) Brian J. Wilson et al. MOLECULAR ENDOCRINOLOGY
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation
- (2010) Matthias G. J. Baud et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Upregulated Histone Deacetylase 1 Expression in Pancreatic Ductal Adenocarcinoma and Specific SiRNA Inhibits the Growth of Cancer Cells
- (2010) Dao-Jian Gao et al. PANCREAS
- HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy
- (2010) O. Khan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
- (2010) C. J. Sneeringer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- Rise of the Rival
- (2010) A. Norvell et al. SCIENCE
- Regulation of Cellular Metabolism by Protein Lysine Acetylation
- (2010) S. Zhao et al. SCIENCE
- AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress
- (2009) Song Hwa Choi et al. BIOCHEMICAL PHARMACOLOGY
- Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors
- (2009) Takayoshi Suzuki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Isoform-specific histone deacetylase inhibitors: The next step?
- (2009) Sriram Balasubramanian et al. CANCER LETTERS
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21
- (2009) Sarah Derks et al. CARCINOGENESIS
- The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
- (2009) Astrid Spannhoff et al. ChemMedChem
- Epigenetic Modifiers: Basic Understanding and Clinical Development
- (2009) R. L. Piekarz et al. CLINICAL CANCER RESEARCH
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Targeting DNA Methylation
- (2009) J.-P. J. Issa et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors
- (2009) Xujun Ma et al. DRUGS
- The promises and pitfalls of epigenetic therapies in solid tumours
- (2009) Janet S. Graham et al. EUROPEAN JOURNAL OF CANCER
- Approaches to target the genome and its epigenome in cancer
- (2009) Nadine Chapman-Rothe et al. Future Medicinal Chemistry
- Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1α (HIF-1α) and p300 by a Zinc Ejection Mechanism
- (2009) Kristina M. Cook et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In VivoResidue-specific Histone Methylation Dynamics
- (2009) Barry M. Zee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a
- (2009) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
- (2009) Gijs van Haaften et al. NATURE GENETICS
- Protein methyltransferases as a target class for drug discovery
- (2009) Robert A. Copeland et al. NATURE REVIEWS DRUG DISCOVERY
- Rethinking how DNA methylation patterns are maintained
- (2009) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
- (2009) Yanqi Chang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Histone methyltransferases in cancer
- (2009) Mareike Albert et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors
- (2008) D.J.P. Ellis et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells
- (2008) W. Fiskus et al. BLOOD
- Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
- (2008) T. Qin et al. BLOOD
- DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications
- (2008) Xia Jiang et al. CANCER CELL
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors
- (2008) N. L. Steele et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- Cancer treatment of the future: Inhibitors of histone methyltransferases
- (2008) Astrid Spannhoff et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- In Situ Generation of a Bisubstrate Analogue for Protein Arginine Methyltransferase 1
- (2008) Tanesha Osborne et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins
- (2008) Philipp Rathert et al. Molecular BioSystems
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- A model for transmission of the H3K27me3 epigenetic mark
- (2008) Klaus H. Hansen et al. NATURE CELL BIOLOGY
- HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
- (2008) D Mottet et al. ONCOGENE
- Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases
- (2008) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started